alendronate

Indications

• Treatment and prevention of postmenopausal osteoporosis.

• Treatment of osteoporosis in men.

• Treatment of Paget's disease of the bone.

• Treatment of corticosteroid-induced osteoporosis in patients (men and women) who are receiving ≥7.5 mg of prednisone/day (or equivalent) with evidence of decreased bone mineral density.